Artículos de revistas sobre el tema "CVB3 infection"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "CVB3 infection".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Lasrado, Ninaad, Rajkumar Arumugam, Mahima T. Rasquinha, Meghna Sur, David Steffen y Jay Reddy. "Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses". Microorganisms 9, n.º 11 (10 de noviembre de 2021): 2323. http://dx.doi.org/10.3390/microorganisms9112323.
Texto completoMone, Kiruthiga, Ninaad Lasrado, Meghna Sur y Jay Reddy. "Vaccines against Group B Coxsackieviruses and Their Importance". Vaccines 11, n.º 2 (27 de enero de 2023): 274. http://dx.doi.org/10.3390/vaccines11020274.
Texto completoGangaplara, Arunakumar, Chandirasegaran Massilamany, Ninaad Lasrado, David Steffen y Jay Reddy. "Evidence for Anti-Viral Effects of Complete Freund’s Adjuvant in the Mouse Model of Enterovirus Infection". Vaccines 8, n.º 3 (7 de julio de 2020): 364. http://dx.doi.org/10.3390/vaccines8030364.
Texto completoFu, Yuxuan y Sidong Xiong. "Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism". PLOS Pathogens 19, n.º 1 (12 de enero de 2023): e1011090. http://dx.doi.org/10.1371/journal.ppat.1011090.
Texto completoGirn, Jaskamal, Mojgan Kavoosi y Janet Chantler. "Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain". Journal of General Virology 83, n.º 2 (1 de febrero de 2002): 351–58. http://dx.doi.org/10.1099/0022-1317-83-2-351.
Texto completoTracy, S., K. M. Drescher, N. M. Chapman, K. S. Kim, S. D. Carson, S. Pirruccello, P. H. Lane, J. R. Romero y J. S. Leser. "Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence". Journal of Virology 76, n.º 23 (1 de diciembre de 2002): 12097–111. http://dx.doi.org/10.1128/jvi.76.23.12097-12111.2002.
Texto completoKemball, Christopher C., Stephanie Harkins, Jason K. Whitmire, Ralph Feuer, Claudia T. Flynn y J. Lindsay Whitton. "Coxsackievirus B3 has profoundly different inhibitory effects on the MHC class I and class II antigen presentation pathways (131.2)". Journal of Immunology 182, n.º 1_Supplement (1 de abril de 2009): 131.2. http://dx.doi.org/10.4049/jimmunol.182.supp.131.2.
Texto completoGao, Guang, Jerry Wong, Jingchun Zhang, Ivy Mao, Jayant Shravah, Yan Wu, Allen Xiao, Xiaotao Li y Honglin Luo. "Proteasome Activator REGγ Enhances Coxsackieviral Infection by Facilitating p53 Degradation". Journal of Virology 84, n.º 21 (18 de agosto de 2010): 11056–66. http://dx.doi.org/10.1128/jvi.00008-10.
Texto completoLasrado, Ninaad, Arunakumar Gangaplara, Rajkumar Arumugam, Chandirasegaran Massilamany, Sayli Pokal, Yuzhen Zhou, Shi-Hua Xiang, David Steffen y Jay Reddy. "Identification of Immunogenic Epitopes That Permit the Detection of Antigen-Specific T Cell Responses in Multiple Serotypes of Group B Coxsackievirus Infections". Viruses 12, n.º 3 (21 de marzo de 2020): 347. http://dx.doi.org/10.3390/v12030347.
Texto completoLasrado, Ninaad, Mahima T. Rasquinha, Meghna Sur, Arunakumar Gangaplara, Chandirasegaran Massilamany, Rajkumar Arumugam, David Steffen y Jay Reddy. "A live-attenuated mutant CVB3 vaccine virus protects against multiple coxsackievirus B infections". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 64.11. http://dx.doi.org/10.4049/jimmunol.208.supp.64.11.
Texto completoNakamura, Yuko, Akikazu Sakudo, Keiichi Saeki, Tomomi Kaneko, Yoshitsugu Matsumoto, Antonio Toniolo, Shigeyoshi Itohara y Takashi Onodera. "Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells". Journal of General Virology 84, n.º 12 (1 de diciembre de 2003): 3495–502. http://dx.doi.org/10.1099/vir.0.19222-0.
Texto completoPinkert, Sandra, Carsten Röger, Jens Kurreck, Jeffrey M. Bergelson y Henry Fechner. "The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection". Journal of Virology 90, n.º 12 (30 de marzo de 2016): 5601–10. http://dx.doi.org/10.1128/jvi.00315-16.
Texto completoChehadeh, Wassim, Julie Kerr-Conte, François Pattou, Gunar Alm, Jean Lefebvre, Pierre Wattré y Didier Hober. "Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated with Alpha Interferon Synthesis in β Cells". Journal of Virology 74, n.º 21 (1 de noviembre de 2000): 10153–64. http://dx.doi.org/10.1128/jvi.74.21.10153-10164.2000.
Texto completoWeller, A. H., K. Simpson, M. Herzum, N. Van Houten y S. A. Huber. "Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis." Journal of Immunology 143, n.º 6 (15 de septiembre de 1989): 1843–50. http://dx.doi.org/10.4049/jimmunol.143.6.1843.
Texto completoKraft, Lisa, Martina Sauter, Guiscard Seebohm y Karin Klingel. "In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell® Cardiomyocytes". Viruses 13, n.º 9 (14 de septiembre de 2021): 1835. http://dx.doi.org/10.3390/v13091835.
Texto completoPatel, Kunal P., Carolyn B. Coyne y Jeffrey M. Bergelson. "Dynamin- and Lipid Raft-Dependent Entry of Decay-Accelerating Factor (DAF)-Binding and Non-DAF-Binding Coxsackieviruses into Nonpolarized Cells". Journal of Virology 83, n.º 21 (26 de agosto de 2009): 11064–77. http://dx.doi.org/10.1128/jvi.01016-09.
Texto completoGoodfellow, Ian G., David J. Evans, Anna M. Blom, Dave Kerrigan, J. Scott Miners, B. Paul Morgan y O. Brad Spiller. "Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors". Journal of Virology 79, n.º 18 (15 de septiembre de 2005): 12016–24. http://dx.doi.org/10.1128/jvi.79.18.12016-12024.2005.
Texto completoEvstropov, A. N., L. G. Burova, O. R. Greck, L. N. Zakharova y T. A. Volkhonskay. "The employment of polyphenol complexes extracted from Pеnthaphylloides fruticosa (L.) O. Scwarz for prophylactic of Coxsackie-virus infection". Bulletin of Siberian Medicine 1, n.º 4 (30 de diciembre de 2002): 27–31. http://dx.doi.org/10.20538/1682-0363-2002-4-27-31.
Texto completoSi, Xiaoning, Honglin Luo, Andrew Morgan, Jingchun Zhang, Jerry Wong, Ji Yuan, Mitra Esfandiarei, Guang Gao, Caroline Cheung y Bruce M. McManus. "Stress-Activated Protein Kinases Are Involved in Coxsackievirus B3 Viral Progeny Release". Journal of Virology 79, n.º 22 (15 de noviembre de 2005): 13875–81. http://dx.doi.org/10.1128/jvi.79.22.13875-13881.2005.
Texto completoKim, Sun-Mi, Jung-Hyun Park, Sun-Ku Chung, Joo-Young Kim, Ha-Young Hwang, Kwang-Chul Chung, Inho Jo, Sang-Ick Park y Jae-Hwan Nam. "Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death". Journal of Virology 78, n.º 24 (15 de diciembre de 2004): 13479–88. http://dx.doi.org/10.1128/jvi.78.24.13479-13488.2004.
Texto completoZhang, Huifang M., Xin Ye, Yue Su, Ji Yuan, Zhen Liu, David A. Stein y Decheng Yang. "Coxsackievirus B3 Infection Activates the Unfolded Protein Response and Induces Apoptosis through Downregulation of p58IPK and Activation of CHOP and SREBP1". Journal of Virology 84, n.º 17 (16 de junio de 2010): 8446–59. http://dx.doi.org/10.1128/jvi.01416-09.
Texto completoHenke, A., C. Mohr, H. Sprenger, C. Graebner, A. Stelzner, M. Nain y D. Gemsa. "Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes." Journal of Immunology 148, n.º 7 (1 de abril de 1992): 2270–77. http://dx.doi.org/10.4049/jimmunol.148.7.2270.
Texto completoZautner, A. E., U. Körner, A. Henke, C. Badorff y M. Schmidtke. "Heparan Sulfates and Coxsackievirus-Adenovirus Receptor: Each One Mediates Coxsackievirus B3 PD Infection". Journal of Virology 77, n.º 18 (15 de septiembre de 2003): 10071–77. http://dx.doi.org/10.1128/jvi.77.18.10071-10077.2003.
Texto completoShim, Seung-Hyun, Dae-Sun Kim y Jae-Hwan Nam. "Coxsackievirus B3 regulates T cell infiltration by LFA-1 modification through Rap1 activation (P5075)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 129.2. http://dx.doi.org/10.4049/jimmunol.190.supp.129.2.
Texto completoYuan, Ji, David A. Stein, Travis Lim, Dexin Qiu, Shaun Coughlin, Zhen Liu, Yinjing Wang et al. "Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry Site". Journal of Virology 80, n.º 23 (20 de septiembre de 2006): 11510–19. http://dx.doi.org/10.1128/jvi.00900-06.
Texto completoLuo, Honglin, Jingchun Zhang, Frank Dastvan, Bobby Yanagawa, Michael A. Reidy, Huifang M. Zhang, Decheng Yang, Janet E. Wilson y Bruce M. McManus. "Ubiquitin-Dependent Proteolysis of Cyclin D1 Is Associated with Coxsackievirus-Induced Cell Growth Arrest". Journal of Virology 77, n.º 1 (1 de enero de 2003): 1–9. http://dx.doi.org/10.1128/jvi.77.1.1-9.2003.
Texto completoWang, Yan, Bo Gao y Sidong Xiong. "Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis". American Journal of Physiology-Heart and Circulatory Physiology 307, n.º 10 (15 de noviembre de 2014): H1438—H1447. http://dx.doi.org/10.1152/ajpheart.00441.2014.
Texto completoKemball, Christopher C., Mehrdad Alirezaei, Claudia T. Flynn, Malcolm R. Wood, Stephanie Harkins, William B. Kiosses y J. Lindsay Whitton. "Coxsackievirus Infection Induces Autophagy-Like Vesicles and Megaphagosomes in Pancreatic Acinar Cells In Vivo". Journal of Virology 84, n.º 23 (22 de septiembre de 2010): 12110–24. http://dx.doi.org/10.1128/jvi.01417-10.
Texto completoOh, Soo-Jin, Jeong-An Gim, Jae Kyung Lee, Hosun Park y Ok Sarah Shin. "Coxsackievirus B3 Infection of Human Neural Progenitor Cells Results in Distinct Expression Patterns of Innate Immune Genes". Viruses 12, n.º 3 (17 de marzo de 2020): 325. http://dx.doi.org/10.3390/v12030325.
Texto completoDan, M. y J. K. Chantler. "A Genetically Engineered Attenuated Coxsackievirus B3 Strain Protects Mice against Lethal Infection". Journal of Virology 79, n.º 14 (julio de 2005): 9285–95. http://dx.doi.org/10.1128/jvi.79.14.9285-9295.2005.
Texto completoVoss, Martin, Sandra Pinkert, Meike Kespohl, Niclas Gimber, Karin Klingel, Jan Schmoranzer, Michael Laue, Matthias Gaida, Peter-Michael Kloetzel y Antje Beling. "A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence". Viruses 14, n.º 4 (7 de abril de 2022): 769. http://dx.doi.org/10.3390/v14040769.
Texto completoShim, Seung-Hyun, Dae-Sun Kim, Whajung Cho y Jae-Hwan Nam. "Coxsackievirus B3 regulates T-cell infiltration into the heart by lymphocyte function-associated antigen-1 activation via the cAMP/Rap1 axis". Journal of General Virology 95, n.º 9 (1 de septiembre de 2014): 2010–18. http://dx.doi.org/10.1099/vir.0.065755-0.
Texto completoLuo, Honglin, Bobby Yanagawa, Jingchun Zhang, Zongshu Luo, Mary Zhang, Mitra Esfandiarei, Christopher Carthy, Janet E. Wilson, Decheng Yang y Bruce M. McManus. "Coxsackievirus B3 Replication Is Reduced by Inhibition of the Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway". Journal of Virology 76, n.º 7 (1 de abril de 2002): 3365–73. http://dx.doi.org/10.1128/jvi.76.7.3365-3373.2002.
Texto completoWong, Jerry, Jingchun Zhang, Xiaoning Si, Guang Gao, Ivy Mao, Bruce M. McManus y Honglin Luo. "Autophagosome Supports Coxsackievirus B3 Replication in Host Cells". Journal of Virology 82, n.º 18 (2 de julio de 2008): 9143–53. http://dx.doi.org/10.1128/jvi.00641-08.
Texto completoShen, Yan, Wei Xu, Yi-Wei Chu, Ying Wang, Quan-Sheng Liu y Si-Dong Xiong. "Coxsackievirus Group B Type 3 Infection Upregulates Expression of Monocyte Chemoattractant Protein 1 in Cardiac Myocytes, Which Leads to Enhanced Migration of Mononuclear Cells in Viral Myocarditis". Journal of Virology 78, n.º 22 (15 de noviembre de 2004): 12548–56. http://dx.doi.org/10.1128/jvi.78.22.12548-12556.2004.
Texto completoWang, Meng-Jie, Chun-Hua Yang, Yue Jin, Chang-Biao Wan, Wei-He Qian, Fei Xing, Xiang Li y Yuan-Yuan Liu. "Baicalin Inhibits Coxsackievirus B3 Replication by Reducing Cellular Lipid Synthesis". American Journal of Chinese Medicine 48, n.º 01 (enero de 2020): 143–60. http://dx.doi.org/10.1142/s0192415x20500081.
Texto completoHan, Tiesuo, Wenqi He, Deguang Song, Kui Zhao, Chenchen Wu, Feng Gao, Huijun Lu et al. "Experimental SSM-CVB3 infection in macaques". Experimental and Molecular Pathology 92, n.º 1 (febrero de 2012): 131–39. http://dx.doi.org/10.1016/j.yexmp.2011.10.008.
Texto completoJagdeo, Julienne M., Antoine Dufour, Gabriel Fung, Honglin Luo, Oded Kleifeld, Christopher M. Overall y Eric Jan. "Heterogeneous Nuclear Ribonucleoprotein M Facilitates Enterovirus Infection". Journal of Virology 89, n.º 14 (29 de abril de 2015): 7064–78. http://dx.doi.org/10.1128/jvi.02977-14.
Texto completoPark, Soo Jin, Uram Jin y Sang Myun Park. "Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson’s disease". PLOS Pathogens 17, n.º 10 (25 de octubre de 2021): e1010018. http://dx.doi.org/10.1371/journal.ppat.1010018.
Texto completoCarson, Steven D., Kyung-Soo Kim, Samuel J. Pirruccello, Steven Tracy y Nora M. Chapman. "Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells". Journal of General Virology 88, n.º 11 (1 de noviembre de 2007): 3031–38. http://dx.doi.org/10.1099/vir.0.82710-0.
Texto completoFirpo, Mason R., Natalie J. LoMascolo, Marine J. Petit, Priya S. Shah y Bryan C. Mounce. "Polyamines and eIF5A hypusination facilitate SREBP2 synthesis and cholesterol production leading to enhanced enterovirus attachment and infection". PLOS Pathogens 19, n.º 4 (18 de abril de 2023): e1011317. http://dx.doi.org/10.1371/journal.ppat.1011317.
Texto completoWang, Yanqi, Zhirong Sun, Hongkai Zhang, Yahui Song, Yi Wang, Wei Xu y Min Li. "CVB3 Inhibits NLRP3 Inflammasome Activation by Suppressing NF-κB Pathway and ROS Production in LPS-Induced Macrophages". Viruses 15, n.º 5 (28 de abril de 2023): 1078. http://dx.doi.org/10.3390/v15051078.
Texto completoXiong, Hai-Rong, Yuan-Ying Shen, Li Lu, Wei Hou, Fan Luo, Hong Xiao y Zhan-Qiu Yang. "The Inhibitory Effect of Rheum palmatum Against Coxsackievirus B3in Vitro and in Vivo". American Journal of Chinese Medicine 40, n.º 04 (enero de 2012): 801–12. http://dx.doi.org/10.1142/s0192415x12500607.
Texto completoKemball, Christopher C., Stephanie Harkins y J. Lindsay Whitton. "Enumeration and Functional Evaluation of Virus-Specific CD4+ and CD8+ T Cells in Lymphoid and Peripheral Sites of Coxsackievirus B3 Infection". Journal of Virology 82, n.º 9 (27 de febrero de 2008): 4331–42. http://dx.doi.org/10.1128/jvi.02639-07.
Texto completoFeuer, Ralph, Ignacio Mena, Robb Pagarigan, Mark K. Slifka y J. Lindsay Whitton. "Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro". Journal of Virology 76, n.º 9 (1 de mayo de 2002): 4430–40. http://dx.doi.org/10.1128/jvi.76.9.4430-4440.2002.
Texto completoBlum, Samuel I., Ashley R. Burg, Yi-Guang Chen y Hubert M. Tse. "MDA5 expression impacts immune cell activation during T1D development". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 61.03. http://dx.doi.org/10.4049/jimmunol.206.supp.61.03.
Texto completoGao, Guang, Jingchun Zhang, Xiaoning Si, Jerry Wong, Caroline Cheung, Bruce McManus y Honglin Luo. "Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice". American Journal of Physiology-Heart and Circulatory Physiology 295, n.º 1 (julio de 2008): H401—H408. http://dx.doi.org/10.1152/ajpheart.00292.2008.
Texto completoBhakat, Soumendranath. "Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease". Molecular BioSystems 11, n.º 8 (2015): 2303–11. http://dx.doi.org/10.1039/c5mb00262a.
Texto completoEsfandiarei, Mitra, Honglin Luo, Bobby Yanagawa, Agripina Suarez, Darya Dabiri, Jianchang Zhang y Bruce M. McManus. "Protein Kinase B/Akt Regulates Coxsackievirus B3 Replication through a Mechanism Which Is Not Caspase Dependent". Journal of Virology 78, n.º 8 (15 de abril de 2004): 4289–98. http://dx.doi.org/10.1128/jvi.78.8.4289-4298.2004.
Texto completoWang, Maowei, Yan Yue, Chunsheng Dong, Xiaoyun Li, Wei Xu y Sidong Xiong. "Mucosal Immunization with High-Mobility Group Box 1 in Chitosan Enhances DNA Vaccine-Induced Protection against Coxsackievirus B3-Induced Myocarditis". Clinical and Vaccine Immunology 20, n.º 11 (11 de septiembre de 2013): 1743–51. http://dx.doi.org/10.1128/cvi.00466-13.
Texto completo